Sargramostim

Sargramostim
Trade Name Leukine
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 1995-03-06 00:00:00
Sponsor Immunex Corporation;51 University Street;Seattle, Washington, 98101
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia